In an interview with CBN, one of Israel’s top doctors is urging more research on Ivermectin as a possible cure for COVID.
Dr. Schwartz told CBN:
“Our study, which was done here, it’s a randomized controlled trial, double-blind. It’s really, I would say, this is the best method that you are doing studies. And our conclusion is that it really has antiviral activities.”
Ivermectin is a cheap drug that has been used for the treatment of parasites in humans and animals for nearly three decades.
It has recently been touted as a possible cure for COVID, but has been met with hostility by the mainstream media who have tagged it as a horse drug, despite it has been approved for human use since the mid 1990s.
Professor Eli Schwartz works for one of the top hospitals in the world, the Sheba Medical Center and has travelled the world combatting tropical diseases such as Ebola and the Dengue Fever.
At the beginning of the pandemic, the Israeli government asked him to research possible cures for the COVID virus.
He is now recommending more study on Ivermectin, after conducting a recent trial on the drug that suggested it helped those who had contracted COVID.
READ: Top Israeli Doctor Says Ivermectin Could Help Treat COVID, Urges More Research AND Top Israeli Professor Conducts Double-Blind Study That Seems to Confirm a Potential Antiviral Drug for COVID
RELATED: French Pasteur Institute study shows how well Ivermectin can treat COVID-19 infection AND Ivermectin, The Drug That Cracked COVID and Treated President Trump AND Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin
WARNING UPDATE: Though several studies suggest Ivermectin may be an effective treatment for COVID, there is increasing evidence that people are self-medicating with the drug, overdosing and poisoning themselves. This is a drug, and it should not be taken without a doctor’s prescription. READ: Kansas medical experts warn against rising self-use of ivermectin to treat COVID-19 AND CDC warns of increased Ivermectin overdoses